Aurinia Pharmaceuticals Inc (AUPH)
5.315
+0.12
(+2.21%)
USD |
NASDAQ |
May 15, 16:00
5.315
0.00 (0.00%)
After-Hours: 16:24
Aurinia Pharmaceuticals Accounts Receivable (Quarterly): 24.09M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 24.09M |
September 30, 2023 | 37.95M |
June 30, 2023 | 19.50M |
March 31, 2023 | 19.05M |
December 31, 2022 | 13.48M |
September 30, 2022 | 41.77M |
June 30, 2022 | 18.17M |
March 31, 2022 | 20.40M |
December 31, 2021 | 15.41M |
September 30, 2021 | 9.814M |
June 30, 2021 | 4.418M |
March 31, 2021 | 1.187M |
December 31, 2020 | 0.00 |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | 0.47M |
June 30, 2019 | 0.248M |
March 31, 2019 | 0.376M |
December 31, 2018 | 0.217M |
September 30, 2018 | 0.759M |
June 30, 2018 | 0.307M |
March 31, 2018 | 0.225M |
December 31, 2017 | 0.109M |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | 0.123M |
December 31, 2016 | 0.086M |
September 30, 2016 | 0.098M |
June 30, 2016 | 0.049M |
March 31, 2016 | 0.047M |
December 31, 2015 | 0.047M |
September 30, 2015 | 0.055M |
June 30, 2015 | 0.085M |
March 31, 2015 | 0.114M |
December 31, 2014 | 0.092M |
September 30, 2014 | 0.05M |
June 30, 2014 | 0.114M |
March 31, 2014 | 0.10M |
December 31, 2013 | 0.106M |
September 30, 2013 | 0.0785M |
June 30, 2013 | 0.1787M |
March 31, 2013 | 0.1838M |
December 31, 2012 | 0.184M |
September 30, 2012 | 0.2123M |
June 30, 2012 | 0.3638M |
March 31, 2012 | 0.9732M |
December 31, 2011 | 0.0451M |
September 30, 2011 | 0.2197M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2020
41.77M
Maximum
Sep 2022
15.06M
Average
15.41M
Median
Dec 2021
Accounts Receivable (Quarterly) Benchmarks
Lexaria Bioscience Corp | -- |
Acasti Pharma Inc | -- |
Edesa Biotech Inc | 0.7436M |
Xenon Pharmaceuticals Inc | 0.833M |
ESSA Pharma Inc | 0.1806M |